
California to Offer Insulin at $11 Per Pen Starting Next Year
Civica Rx, in collaboration with Biocon Biologics, is also working to develop additional interchangeable biosimilar insulins California will begin selling CalRx insulin glargine pens to consumers starting Jan. 1, 2026, at a suggested retail price of no …